RESEARCH DOSSIER
Psychotherapy in Later Life, Disability, and Medical Comorbidity
Abstract. This fundamental research monograph examines psychotherapy at the intersection of aging, disability, and coexisting medical disease. It asks how depressive, anxious, adjustment-related, and pain-related difficulties are conceptualized and treated when functional capacity, cognition, sensory access, multimorbidity, and service coordination alter the conditions of treatment. A critical narrative synthesis integrates original randomized trials, systematic reviews, network meta-analysis, professional guidelines, and methodological analysis through November 3, 2026. Evidence supports several structured psychotherapies for later-life depression, adapted interventions for selected disability groups, and collaborative-care programs for mental–physical comorbidity. It also reveals limitations in trial representativeness, adaptation-specific causal evidence, adverse-effect reporting, and long-term patient-centered outcomes. The resulting framework links therapeutic mechanism, accessible delivery, clinical formulation, and coordinated medical care.
Keywords: geropsychology; psychotherapy; late-life depression; disability; medical comorbidity; multimorbidity; cognitive-behavioral therapy; behavioral activation; problem-solving therapy; intellectual disability; cognitive impairment; dementia; chronic pain; collaborative care; telepsychotherapy; accessibility; rehabilitation; treatment outcomes.
Scientific Scope and Research Questions
Psychotherapy in later life, disability, and medical comorbidity is the study of psychological treatments as they are delivered to people whose lives involve age-related transitions, functional limitations, disabling environments, chronic medical conditions, or combinations of these circumstances. Its principal unit of analysis is a therapeutic intervention situated within a particular pattern of psychological symptoms, capacities, participation opportunities, and medical care. The subject encompasses depression and anxiety treatment, adjustment to illness, support for coping and functioning, delivery accommodations, therapeutic relationships, and coordination between psychological and physical health services. The relevant clinical question is how effective psychological care can remain accessible, meaningful, and measurable across heterogeneous populations.
Later life, disability, and medical comorbidity are analytically separable dimensions. Older adults vary substantially in health and functional capacity. Disabilities may begin early or late, arise from sensory, motor, cognitive, intellectual, or fluctuating conditions, and be intensified by barriers in service environments. Medical comorbidity refers to coexisting conditions and treatment demands, not simply to age. A younger person with complex disability may require adaptations similar to those of an older person, whereas a physically healthy older person may need ordinary evidence-based treatment without modifications. Conflating these groups risks substituting a demographic label for a clinical formulation.
This monograph investigates five linked questions: which treatment models have evidence of benefit; how trial results change when disability or chronic disease coexists; which delivery modifications preserve therapeutic mechanisms; how outcomes should be measured when symptoms, illness effects, and functioning overlap; and which uncertainties remain concerning access, equity, safety, and durability. It integrates randomized trials, evidence syntheses, clinical guidelines, and methodological analysis. The approach is a critical narrative research synthesis, with explicit discussion of study design and certainty, rather than a new experiment or a protocol-driven systematic review.
Historical Development of Geropsychotherapy and Integrated Care
The development of psychotherapy for older people followed changes in clinical expectations about aging. Earlier psychiatric services frequently interpreted distress in advanced age through assumptions of inevitable decline and treatment resistance. Research on depressive disorders, cognitive-behavioral treatment, interpersonal processes, and rehabilitation progressively challenged the assumption that psychological change depended on youth. The decisive methodological shift was the enrollment of older people in treatment trials with standardized assessment, independent comparison conditions, and follow-up measurements.
Maintenance research illustrates a second shift: geriatric treatment goals expanded from short-term symptom relief to preventing recurrent depressive episodes. Reynolds (1999) investigated pharmacological and interpersonal psychotherapy maintenance approaches in patients over age 59 with recurrent major depression. That study belongs to a combined-treatment history and cannot establish that every psychotherapy format offers equivalent protection from recurrence. Its importance is the move toward studying relapse, continuation, and the interaction between psychological and medical components of care.
A third shift concerned delivery systems. The Unützer (2002) evaluated collaborative management of late-life depression in primary care, moving treatment from a specialist-only model into routine health settings. Subsequent work, including Katon (2010), assessed coordinated management of depression alongside diabetes and coronary heart disease. These studies explain why contemporary psychotherapy research must evaluate the organization of care in addition to the psychological technique itself.
The history of disability-specific adaptation also changed the presumed relationship between intervention fidelity and accessibility. Research began to distinguish the central therapeutic operation, such as identifying achievable activities or examining patterns of thinking, from incidental features such as standard reading materials, session length, and spoken-language demands. Accessible delivery became a researchable dimension of treatment design. Recent evidence on intellectual disability provides systematic classifications of adaptation practices, while retaining the question of which adaptations independently improve outcomes Poku (2026).
Population Definitions and Clinical Heterogeneity
Research samples often define an older person using an age threshold, commonly 60 or 65 years, but the boundary is conventional and varies across studies. The American Psychological Association. (2024). Guidelines for psychological practice with older adults. American Psychological Association. https://www.apa.org/practice/guidelines/older-adults.aspx (2024) explicitly situate aging within social experience, environmental resources, cognition, and functional capacity. A participant aged 55 with advanced illness may share treatment barriers with an individual aged 85; the two may also differ substantially in learning history, medication exposure, life expectancy, and social support. Chronological age must therefore be accompanied by meaningful measures of health, disability, and participation.
Medical comorbidity likewise requires operational specification. A diagnosis count alone does not describe clinical complexity. Two conditions may interact through fatigue, symptom overlap, polypharmacy, mobility restrictions, financial burden, or conflicting appointments. A person's priorities may be to alleviate depression, regain social participation, manage pain interference, maintain autonomy, or reduce avoidable acute care. Treatment studies that report only one symptom scale omit dimensions that often determine whether an intervention is useful.
Disability entails both individual variations in functioning and the accessibility of environments. Distinctions among intellectual disability, acquired cognitive impairment, sensory loss, mobility impairment, and chronic pain matter because each can demand a different therapeutic accommodation. Cognitive impairment may affect memory for therapeutic assignments; a vision impairment affects format rather than reasoning ability; hearing loss affects communication channel; mobility limitation affects attendance. The same diagnostic term cannot be used as a proxy for the patient's capacity to engage in psychotherapy.
Intersecting social factors influence recruitment and retention. Income, transport, caregiving commitments, digital access, health literacy, cultural meanings of help-seeking, and availability of interpreters can alter treatment exposure and apparent effectiveness. These variables are partly determinants of outcome and partly determinants of who enters a trial. Both roles must be represented when transporting trial findings to clinical services.
Clinical Formulation Across Mental and Physical Health
An adequate formulation connects presenting distress to the circumstances in which it occurs. Depression may coexist with pain, sleep disruption, grief, social isolation, functional loss, or fear of disease progression. Anxiety may center on falls, medical procedures, dependence, uncertainty, or a prior psychiatric disorder. A patient may experience several of these processes simultaneously. A formulation that attributes every symptom to chronic disease risks overlooking treatable depression; one that interprets physical symptoms entirely as depression risks overlooking medical pathology.
The NICE guideline on depression with a chronic physical health problem recommends comprehensive assessment of psychological symptoms, functioning, previous episodes, other disorders, interpersonal context, and the clinical illness. Its instruction to consider learning disabilities and acquired cognitive impairment is important because assessment and treatment delivery need to reflect communication and cognitive capacities. The guideline also directs clinicians to examine the role of prescribed medication and the adequacy of medical treatment in the clinical picture.
Clinical formulation should identify maintainers that can realistically be modified. Examples include reduced access to reinforcing activity, avoidance after a frightening medical event, isolation following loss of transportation, catastrophic interpretation of bodily sensations, helplessness about symptom fluctuation, or a breakdown in practical problem-solving. Treatment then targets these mechanisms while accepting the real constraints imposed by illness. The intervention should not imply that a medical condition is caused by a person's thoughts.
Goal formulation is collaborative. Where the medical course is progressive, a meaningful outcome may be better decision-making, less suffering, preserved relationships, or attainable participation, even when impairment cannot be reversed. Where rehabilitation is possible, return to selected tasks or social roles may be central. Both cases require explicit attention to the patient's values and consent.
Evidence Hierarchy and the Problem of Treatment Comparators
The strength of evidence depends on the specific causal claim. Randomized trials can estimate the effect of assignment to a defined intervention relative to the trial's comparison condition. Waitlist, usual care, attention control, supportive therapy, and an active evidence-based treatment answer different questions. A large advantage over a waitlist does not establish an advantage over competent alternative care. Outcomes measured immediately after treatment are distinct from durability over a year or longer.
The Cuijpers (2026) combined 86 randomized trials involving 10,165 participants to compare several psychological treatments for depression among older adults. It reported benefits for cognitive-behavioral, behavioral activation, problem-solving, and life-review therapies relative to care as usual or waitlist. The authors found that the apparent superiority of life review over certain treatments was sensitive to outlier handling and disagreement between direct and indirect evidence. The appropriate inference is support for several treatment families, accompanied by uncertainty about their precise ranking.
Trial eligibility is a decisive limitation. Patients with substantial multimorbidity, severe sensory barriers, fluctuating cognition, or advanced disease may be underrepresented, even where their needs are common in practice. Extrapolation requires assessing whether the patient could have entered the trial, whether the intervention could be delivered, and whether the outcome is meaningful in their circumstances. Standardized mean differences across symptom instruments are informative at the group level but cannot be read as individualized predictions.
Systematic-review protocols should be distinguished from completed evidence syntheses. Ang (2024) published a Cochrane intervention-review protocol specifying an intended evaluation of psychotherapeutic treatments for depression in older adults; it does not provide pooled results. Treating protocols as findings would manufacture consensus where data analysis has not yet occurred.
Cognitive-Behavioral Therapy and Behavioral Activation
Cognitive-behavioral therapy (CBT) organizes treatment around relations among interpretations, emotion, activity, avoidance, and reinforcement. For older adults with depression, its relevance includes routines disrupted by bereavement, health restrictions, diminished social contacts, and fear of further functional loss. Treatment components may include activity scheduling, identifying unhelpful predictions, behavioral experiments, and structured coping with stress. When illness is irreversible, cognitive work concerns the implications assigned to the condition and feasible choices within it.
Behavioral activation focuses on increasing contact with personally meaningful, attainable activities. Its mechanism is especially relevant when disability and illness reduce opportunities for engagement. A therapist may distinguish medical restrictions from behavior patterns that have narrowed unnecessarily; activity goals must respect endurance, safety, and medical advice. Success is assessed in participation, agency, and mood rather than a mechanical count of tasks.
The synthesis of Cuijpers (2026) supports CBT and behavioral activation among effective treatments for later-life depression, yet the average effects come from heterogeneous outpatient trials. A specific activity intervention for a person with severe physical impairment needs evidence for the adapted delivery and a rationale connecting the task to therapeutic reinforcement. Generic assignments such as increasing walking may be inaccessible; equivalent psychological functions may be served by seated creative activity, accessible social engagement, or participation through assistive technologies.
Treatment manuals provide a structure for fidelity. Adaptive modifications should be recorded as modifications to presentation, pacing, example selection, and homework modality, while the proposed mechanism remains inspectable. An adapted treatment that is never evaluated cannot inherit every efficacy claim from its unadapted origin merely because it retains the same therapeutic name.
Problem-Solving Therapy and Executive Function
Problem-solving therapy (PST) addresses the relationship between depressive symptoms and failures or barriers in everyday problem resolution. It typically moves through defining a concrete problem, generating options, selecting a feasible plan, implementing it, and evaluating the result. For people facing complex medical schedules or reduced resources, this framework can translate overwhelming challenges into smaller decisions. Its therapeutic effect may combine increased perceived control with actual changes in day-to-day circumstances.
Executive dysfunction is a particularly important moderator to investigate. Planning, initiation, cognitive flexibility, and monitoring may be disrupted by neurological conditions or other processes. In an original randomized trial, Areán (2010) compared problem-solving therapy with supportive therapy among depressed older adults with executive dysfunction. The research provides a specific example of treatment testing in a cognitively characterized subgroup. Its findings should be understood within its trial population and outcome definitions, rather than as proof of universal superiority for all cognitive difficulties.
A treatment can also compensate for cognitive demands. Written or pictorial prompts, repetition, shorter steps, and review of between-session plans may reduce memory and executive burdens. The empirical question becomes whether these modifications increase adequate exposure to the therapeutic procedure and improve meaningful outcomes. A therapist should distinguish difficulties resulting from cognition from lack of motivation or resistance.
PST integrates naturally with collaborative care because actionable barriers often concern several services: obtaining transport, scheduling visits, securing equipment, or requesting a medical review. These tasks can be psychological treatment targets when they maintain distress, while responsibility for diagnosis and clinical decisions remains with qualified professionals.
Interpersonal Psychotherapy, Social Roles, and Life Transitions
Interpersonal psychotherapy (IPT) treats symptoms through changes in relationships, roles, conflict, grief, and social connection. Later life may involve retirement, bereavement, caregiving, altered intimacy, relocation, and changes in dependence. A disability may modify social roles without eliminating the individual's need for reciprocity and agency. Such transitions provide a coherent focus for interpersonal treatment when they are meaningfully related to the clinical problem.
The maintenance trial by Reynolds (1999) placed IPT within a longer-term recurrence-prevention design involving pharmacotherapy. It highlights the need to distinguish acute response, maintenance prevention, and combined treatment. Evidence supporting a particular maintenance arrangement should not be reinterpreted as establishing the same effect for IPT alone or for medically complex populations outside the trial.
Social relationships operate as resources and stressors. Some patients experience protective support from partners or adult children; others encounter conflict, overprotection, financial dependence, or institutional restrictions. Therapy can examine communication, negotiated assistance, and the preservation of personal choice. Involving relatives may improve implementation when welcomed by the patient, but the individual's confidential therapeutic space and consent remain central.
Research on interpersonal adaptation is limited by variations in treatment definition, patient selection, and the use of combined treatment. In practice, the relationship-focused approach must be matched to a specific interpersonal formulation rather than selected solely because someone is older or disabled.
Life Review, Reminiscence, and Autobiographical Meaning
Life review interventions use structured autobiographical reflection to examine personal history, unresolved experiences, sources of meaning, identity, and continuity. Later-life psychotherapy may draw on remembered accomplishments, difficult transitions, and enduring relationships to support a coherent sense of self. These methods are distinct from informal reminiscence when they specify a therapeutic rationale, structured process, and defined outcomes.
The Cuijpers (2026) included life-review therapy alongside other studied approaches for older-adult depression. Life review appeared favorable in several comparisons, but the finding that it exceeded particular alternatives was attenuated after outlier exclusion. The analysis therefore supports life review as a plausible effective approach while constraining claims that it should replace CBT or PST in all settings.
Autobiographical work requires sensitivity to trauma, marginalization, culturally shaped narratives, and cognitive conditions. A structured exercise may evoke grief, shame, or unresolved conflict; session pacing and clinical monitoring remain important. When memory is impaired, the use of photographs or trusted supporters may increase accessibility, but it may also shift control of the narrative toward others. The patient's interpretation of a life event remains the clinical focus.
The relationship between meaning-making and depression reduction requires clearer mechanism tests. Improvement could arise through narrative coherence, therapeutic attention, behavioral engagement, social connection, or combinations of these processes. Randomized dismantling studies and longitudinal mediation analyses are needed before attributing benefits to one proposed pathway.
Depression and Anxiety Prevention in Advanced Age
Indicated prevention targets people who have meaningful risk or subthreshold symptoms but do not meet criteria for a current disorder. It must be distinguished from treating diagnosed major depression. Stepped approaches may begin with monitoring and structured low-intensity intervention before moving to more intensive treatment if symptoms persist. This sequence can conserve specialist resources, provided that serious clinical conditions and safety concerns are recognized promptly.
In a Dutch randomized trial, van't Veer-Tazelaar (2009) recruited 170 people aged 75 or older with subthreshold depression or anxiety. At 12 months, reported incidence of a depressive or anxiety disorder was 12% in the stepped-care group and 24% under usual care, with a relative risk of 0.49 and a confidence interval of 0.24 to 0.98. The sequence involved watchful waiting, CBT-based bibliotherapy, problem-solving treatment, and possible referral. The estimated effect belongs to this selected, relatively small prevention sample and should not be generalized to all older adults.
Prevention research faces distinct validity problems. Movement from subthreshold scores to diagnostic categories depends on measurement decisions, follow-up interval, and the clinical course of illness. Regression toward the mean, spontaneous remission, and variable exposure to preventive activities can affect estimates. Furthermore, access to printed or digital materials is uneven among people with sensory or cognitive disabilities.
Long-term prevention requires attention to social conditions. Housing insecurity, isolation, inaccessible services, and untreated medical symptoms can maintain distress independently of psychological skills. An evidence-based prevention program should offer appropriate coordination when the sources of risk extend beyond the therapist's intervention.
Primary-Care Collaborative Treatment and the IMPACT Trial
Collaborative care is a service model in which primary-care clinicians, care managers, and mental-health specialists share defined responsibilities for assessment, active treatment, monitoring, and adjustment. It differs from simply placing a psychologist within a medical clinic. The model requires scheduled follow-up, outcome measurement, and a clinical response to insufficient improvement. Its relevance increases when patients face multiple appointments and require continuity across disciplines.
The Unützer (2002) randomized older primary-care patients with depression to collaborative management or usual care. The intervention combined care management, treatment options, and specialist supervision. It demonstrated the feasibility and clinical value of a coordinated system for late-life depression. Because multiple components were delivered together, trial results cannot isolate the specific contribution of psychotherapy from follow-up intensity, medication management, or other elements.
Collaborative care is relevant to disability because the pathway through services may be part of the intervention burden. A patient with impaired mobility may benefit from consistent telephone follow-up, an agreed care coordinator, and fewer redundant assessments. A patient with cognitive impairment may require explicit review of care plans in accessible formats. Coordination must respect privacy, role boundaries, and the patient's preferences about who receives information.
Service outcomes should include both symptom reduction and implementation measures: treatment initiation, sufficient dose, attendance, discontinuation, medical coordination, and functional improvement. Trials showing benefit in one health system may require adaptation for different payment systems, workforce arrangements, and community resources.
Depression Combined With Diabetes and Coronary Disease
The clinical interaction of depression with chronic somatic disease extends beyond the coexistence of diagnoses. Depressive symptoms can interfere with self-care, symptom interpretation, appointments, and motivation; disease activity and treatment burdens can in turn affect emotional functioning. Establishing causal direction requires appropriate longitudinal and experimental evidence. A cross-sectional association between higher symptom burden and poorer disease control does not by itself show that psychotherapy will normalize physical biomarkers.
In the Katon (2010), 214 patients with depression and poorly controlled diabetes, coronary heart disease, or both received coordinated management or usual care in primary-care clinics. The program combined medical and mental-health targets within one treatment system. Its contribution is evidence for integrated management of multiple conditions, not an isolated efficacy estimate for a single psychotherapy technique. Disease-specific endpoints, psychiatric endpoints, and patient-centered measures need to be interpreted separately.
Medical treatment imposes additional constraints on psychological practice. Fatigue, neuropathy, cognitive effects of illness, treatment schedules, and acute complications may interrupt sessions. Planning around these demands can improve access without assuming that psychotherapy substitutes for appropriate endocrinologic or cardiovascular treatment. The medical team retains responsibility for diagnosis, medication decisions, and disease management.
A generalizable integrated-care model must specify who monitors each condition, how information is shared, how deterioration triggers escalation, and which goals the patient considers important. Without these operational details, the term collaborative care becomes too broad to describe a reproducible intervention.
Chronic Pain, Functioning, and Acceptance-Based Treatment
Chronic pain frequently involves reciprocal relationships among sensory experience, activity restriction, sleep disruption, threat appraisal, mood, and social participation. Psychological treatment aims to change coping processes and pain-related interference while respecting the reality of nociceptive and neuropathic mechanisms. Psychological approaches may benefit function and distress even if pain intensity remains substantial. This makes selection of the outcome especially important.
Acceptance and commitment therapy (ACT) emphasizes flexible engagement with valued action and the ability to respond to difficult internal experiences without persistent, ineffective avoidance. A Ma (2023) synthesized 21 trials involving 1,962 participants with chronic pain. Reported group differences favored ACT across several psychological and functional outcomes, although comparator types included waitlist, usual care, and active treatments. The effect estimate for a particular endpoint should not be substituted for an effect on every clinical dimension.
A separate Lai (2023) examined 33 randomized trials and identified modest improvements in pain-related and psychological outcomes, with variations across delivery conditions. These reviews overlap in underlying research and are not two independent replications of the whole evidence base. Mechanism claims involving acceptance and flexibility require careful measurement because self-report processes and self-reported disability may share method variance.
Psychotherapy for chronic pain often takes place alongside rehabilitation and medication. Joint goals may involve pacing, valued participation, and reducing activity avoidance. The therapeutic formulation should distinguish medically contraindicated activity from unnecessarily restricted behavior, and should not suggest that willingness to endure symptoms is a substitute for clinical assessment or pain management.
Depression and Pain as Coexisting Treatment Targets
Pain and depressive symptoms commonly reinforce one another through reduced sleep, lower activity, fear, and disengagement. Treatment programs may therefore address affective symptoms and practical management of pain-related interference. An integrated intervention must define which components treat mood, which affect pain coping, and which involve medical treatment rather than psychotherapy alone.
The Kroenke (2009) randomized 250 primary-care patients with depression and persistent musculoskeletal pain to a combined program or usual care. The tested package sequenced optimized antidepressant management with pain self-management. At 12 months, a substantially greater proportion of the intervention group met a prespecified depression-response threshold. This finding concerns the entire combined program. It cannot be assigned wholly to psychotherapy because pharmacological optimization formed part of the intervention.
Clinical trials with combined targets must predefine outcome hierarchies. Improvements in depression, pain severity, pain interference, and health-related quality of life may occur at different rates. Studies that combine several scales without a primary endpoint make interpretation vulnerable to selective emphasis on favorable results. The presence of a clinically meaningful effect should be tested against minimal important differences where these are established.
Multimorbidity is also associated with treatment burden. Patients may already receive extensive rehabilitation, specialist appointments, and medication monitoring. An effective intervention has to earn its additional demands by addressing goals that matter to the patient, rather than automatically increasing the number of prescribed activities or forms.
Psychotherapy With Intellectual Disability
Intellectual disability affects conceptual learning, communication, adaptive functioning, and the level of support needed for certain tasks. It does not remove the capacity to experience depression, anxiety, attachment, or therapeutic benefit. Clinical accessibility depends on adjusting explanations, pace, communication media, and the structure of involvement by supporters. An adapted psychotherapy model should preserve the patient's own preferences, assent, and decision-making participation wherever possible.
The Jahoda (2017) randomized 161 adults with mild to moderate intellectual disabilities and clinically significant depression to individualized behavioral activation or guided self-help. The primary depression outcome at 12 months showed no statistically significant difference between the two active interventions. Both groups improved from baseline, but within-group improvement alone does not establish the effect of either treatment relative to an untreated control. The main controlled conclusion is that BeatIt was not shown superior to StepUp in that comparison.
A smaller randomized study by Cooney (2017) evaluated a computer-assisted CBT program for adults with mild to moderate intellectual disability and anxiety or depression. Its reported results favored the adapted intervention for anxiety measures, while the depression primary outcome was not similarly supported. Small sample size, short follow-up, and a specific delivery program limit generalization.
The Poku (2026) classified adaptations across 122 eligible studies into multisensory methods, activities, communication, delivery medium, additional support, and structure. The classification is useful for specifying treatment accessibility. The review also indicated that stronger studies are necessary to establish whether particular modifications produce better clinical effects.
Sensory, Mobility, Communication, and Environmental Access
Sensory and mobility conditions introduce barriers that are often external to the psychological mechanism under treatment. Hearing loss may require written communication, assistive listening devices, accessible video captioning, or sign-language interpretation. Visual impairment may require compatible screen-reader content, audio materials, tactile or verbally described exercises, and careful layout. A person using a wheelchair may need accessible premises or remote sessions. These modifications enable access to the treatment; they do not automatically change the diagnosis or therapeutic objective.
The principle of accommodation is supported by professional guidance. The American Psychological Association. (2024). Guidelines for psychological practice with older adults. American Psychological Association. https://www.apa.org/practice/guidelines/older-adults.aspx (2024) emphasize understanding functional capacity in the person's environment and adapting interventions. The NICE chronic-physical-health guideline specifically recommends adjusting the delivery or duration of interventions when cognitive or learning difficulties make standard presentation inappropriate. Such recommendations are practice guidance and should be distinguished from evidence that one accommodation strategy is the most effective.
Accessibility must be verified with the patient. A large-font workbook may remain unusable for someone relying on audio; a video session may be inaccessible without reliable connectivity or appropriate interpretation; a caregiver acting as a communication bridge may inadvertently limit privacy. Clinicians should document the preferred modality and whether information was understood, not assume that provision of a device equals successful participation.
Research needs more trials that explicitly report accessibility measures. Usual trial descriptions rarely quantify accommodation requests, implementation success, and attrition linked to accessibility. Without these data, intervention effectiveness may be estimated among those who could tolerate the original delivery format while the least-served population remains invisible.
Mild Cognitive Impairment and Dementia
Cognitive impairment creates a spectrum of therapeutic considerations rather than a single contraindication. Mild cognitive impairment may affect specific cognitive domains while preserving independence in many daily tasks; dementia can involve increasing support needs and changes in decisional capacity, language, memory, and behavior. Depression and anxiety can coexist with either condition. Assessment must establish the patient's current abilities and the status of relevant medical evaluations.
The Orgeta (2022) assessed psychological treatments for depression and anxiety among people with dementia or mild cognitive impairment. It found that CBT-based interventions probably confer small benefits on depression, quality of life, and daily functioning at the end of treatment. Evidence for anxiety outcomes and several other psychotherapy modalities was more limited. Trial samples were weighted toward milder cognitive conditions, constraining applicability to advanced dementia.
The World Health Organization. (2023). Psychological therapies for people with dementia and comorbid depression [mhGAP evidence recommendation]. https://www.who.int/teams/mental-health-and-substance-use/treatment-care/mental-health-gap-action-programme/evidence-centre/dementia/psychological-therapies-for-people-with-dementia-who-have-associated-depression (2023) is conditional, with low certainty, and identifies several psychological approaches that can be considered for mild-to-moderate depression. A conditional recommendation establishes a potential role for treatment with careful individual assessment; it does not imply uniform benefit for all dementia stages.
Adaptations may include repeated orientation to the session, simplified goals, visible reminders, shorter sequences, and a negotiated role for trusted supporters. The research challenge is preserving therapeutic agency when memory, communication, or consent capacity fluctuate. Outcome measures should include distress and participation, caregiver reports when appropriate, and patient-expressed experiences wherever these can be reliably obtained.
Cognitive Assessment, Delirium, and Diagnostic Boundaries
Cognitive and emotional symptoms can overlap. Reduced concentration, slowed processing, fatigue, sleep disturbance, and apparent disengagement may be associated with depression, neurological disease, medication effects, sensory obstacles, or an acute medical change. Screening is a starting point rather than a replacement for diagnosis. A clinically informed approach considers onset, variability, functional change, medication exposure, and any urgent signs of medical illness.
Delirium and other acute disturbances require prompt medical assessment. A sudden fluctuation in awareness or attention should not be treated as an ordinary psychotherapy engagement problem. Therapy sessions may need to be interrupted or rescheduled when acute physical instability affects cognition. Similarly, persistent cognitive deficits require appropriate assessment without presuming that psychotherapy will reverse their medical basis.
The American Psychological Association. (2024). Guidelines for psychological practice with older adults. American Psychological Association. https://www.apa.org/practice/guidelines/older-adults.aspx (2024) call for competence in cognitive and functional evaluation and suitable instruments. The clinical purpose of cognitive assessment in psychotherapy is to understand capacity for informed participation, available learning modalities, safety needs, and reasonable goals. Such assessment should be appropriately conducted or referred to qualified clinicians.
Cognitive impairment is frequently measured with instruments influenced by education, language, sensory access, and cultural familiarity. A low score may partly reflect barriers in the assessment process. Adaptation and interpretation must therefore be documented, particularly when a measure affects eligibility for therapy or determines the level of supporter involvement.
Measurement of Depression, Functioning, and Quality of Life
Measurement in medically complex psychotherapy should distinguish symptom severity, disorder status, functioning, and the patient's own treatment goals. A depression instrument may capture fatigue, insomnia, or appetite change arising partly from medical illness. An anxiety instrument may conflate medically justified vigilance with pathological threat anticipation. Raw scores need interpretation in the context of disease activity and the scale's intended use.
Trials demonstrate that different outcomes can tell different stories. Choi (2020) examined depressive symptoms, disability, social engagement, and satisfaction with social roles in a telehealth trial for homebound older adults. Katon (2010) examined psychiatric and physical-health targets within collaborative care. Both illustrate the value of multidomain measurement when the intervention addresses more than depressive mood.
A sound outcome framework identifies the primary endpoint before reviewing results, reports changes and uncertainties, and includes adverse experiences. Functional improvements should be defined in relation to baseline capacity and desired participation; requiring the same physical milestone from everyone would conflate intervention effectiveness with preexisting impairment. Where patient-reported outcomes are inaccessible, adapted or supported measurement needs validation rather than casual substitution.
Longitudinal measurement is essential because symptom recovery, regained participation, and medical progression can move in different directions. A treatment might improve psychological functioning while a degenerative medical condition progresses. Such divergence does not imply failure if the agreed endpoint concerns distress, choice, relationships, or attainable functioning.
Psychometric Validity and Measurement Invariance
Psychometric instruments must be reliable and valid for the population and purpose in which they are used. A scale developed in generally healthy middle-aged adults may not operate identically in people with substantial physical illness, hearing difficulties, or cognitive impairment. Comparability depends on whether item content, response format, and interpretation reflect the same underlying construct. A single cutoff score should not be presumed universally transferable.
Measurement invariance offers one formal approach to testing whether an instrument measures constructs comparably across groups. Differential item functioning may arise when a somatic item is more likely to be endorsed by medically ill participants at the same level of depression. Language adaptation and assistive presentation introduce further potential sources of response variation. These issues can alter estimates of prevalence and treatment response.
Patient-reported quality of life, functional participation, and symptom relief can also be affected by changes in expectations and personal priorities. Researchers should specify whether they intend to measure absolute ability, perceived participation, or satisfaction with adapted roles. A person may report improved quality of life after adjustment while objective physical capacity remains stable.
Future psychotherapy trials should preregister measurement decisions, report subgroup performance where sample sizes allow, and collect multiple indicators to determine whether change is robust. The choice of instrument is part of the scientific model rather than merely an administrative detail.
Treatment Adaptation and Fidelity
Treatment adaptation involves changing delivery features so that a therapeutic process can operate in a particular context. Examples include reducing cognitive load, converting written assignments to audio, providing accessible diagrams, offering shorter or more frequent sessions, involving approved supporters, and coordinating timing with medical care. Fidelity concerns whether the active therapeutic operation is retained and delivered competently. Adaptation and fidelity can be complementary when mechanisms are clearly specified.
Poku (2026) identified six broad classes of adaptations in psychotherapy studies involving intellectual disability. This taxonomy supplies a vocabulary for reporting what was changed. It does not imply that all modifications are equally effective or that a particular class should be applied to every patient. The study of adaptation must progress from documenting feasibility to comparative evaluation and identification of mediating mechanisms.
An intervention can lose fidelity through omission of essential practice, but rigid adherence can also undermine access when a patient cannot use the chosen format. Researchers should record both the therapeutic ingredient and the adaptation, along with treatment exposure, comprehension, homework completion, and adverse effects. This helps distinguish an ineffective theory from an intervention that was never adequately delivered.
Adaptive treatment protocols may include decision rules specifying when to alter pacing, format, session setting, or caregiver involvement. Such rules should be transparent and testable. Future trials can compare optimized adaptation strategies rather than merely comparing a standard manual with an unspecified collection of clinician adjustments.
Telepsychotherapy, Homebound Care, and Digital Access
Remote psychotherapy can reduce travel, transport, and mobility barriers, especially for people who are homebound or live far from specialist services. Access, however, depends on devices, connectivity, sensory compatibility, privacy, and technical assistance. The presence of video technology does not remove digital exclusion. Telephone-only care, videoconferencing, and asynchronous programs also differ in therapeutic interaction and evidence.
In a noninferiority trial among older veterans with depression, Egede (2015) compared home-based telemedicine psychotherapy with in-person treatment. The prespecified noninferiority criteria were met within the study's design. This supports feasibility and effectiveness of remote delivery for selected patients and a defined protocol; it does not prove equivalence for every disorder, sensory condition, or technological arrangement.
In a separate randomized trial, Choi (2020) recruited 277 homebound adults aged 50 or older with depressive symptoms. Video-delivered behavioral activation by trained lay counselors and problem-solving therapy by licensed clinicians were compared with telephone support. Both active approaches improved depression outcomes relative to attention control; clinician-delivered problem-solving therapy performed better on the primary depression measure, while other outcomes did not show the same contrast. The study's population and treatment packages matter for interpretation.
Remote care raises practical governance questions. Therapists require a plan for interruptions, local emergency response, privacy at home, participant identification, and support for people with cognitive or sensory limitations. An accessible remote option is a meaningful extension of care only when those arrangements permit a safe and sufficiently private therapeutic process.
Caregivers, Supporters, and Therapeutic Autonomy
Family members, paid supporters, and informal caregivers may be essential for transport, communication, scheduling, or between-session implementation. Their roles should be specified rather than assumed. A supporter may facilitate access to an exercise while also holding information or preferences different from those of the person in therapy. Treatment research often underreports this interpersonal complexity.
Involving a supporter may assist an individual with intellectual disability in remembering goals and completing structured tasks. The Poku (2026) includes additional support as a recurrent adaptation category. Yet benefit depends on consent, trust, communication, and the supporter's own understanding of the intervention. Supporter involvement should never be treated as automatic authority over the patient's experiences.
The therapist must maintain a distinguishable therapeutic relationship with the person receiving treatment. When possible, private time, accessible consent explanations, and explicit rules about information sharing preserve autonomy. Where decisional capacity is limited, applicable law and professional standards govern substitute decision-making and assent. Capacity can be task-specific and may vary over time.
Research should report whether caregivers were trained, how often they attended, what information they received, and whether their presence changed outcomes or retention. These data would help distinguish a clinical mechanism from a logistical requirement of treatment access.
Serious Illness, Palliative Contexts, and Dignity
Psychotherapy in advanced or life-limiting illness may focus on distress, fear, demoralization, role continuity, family communication, or meaning. Treatment goals should be selected with the person and integrated with palliative and medical care. Physical suffering, dependence, and uncertainty have real causes; psychological treatment addresses the experience and management of these circumstances alongside appropriate symptom relief.
Chochinov (2011) in a multisite randomized trial involving patients near the end of life. The study compared a structured, individualized psychotherapeutic intervention with other care conditions. Its relevance lies in a treatment approach organized around meaning and personhood in serious illness. Endpoint selection and the possibility of benefits in existential experience must be distinguished from effects on clinical depression or survival.
Interventions in palliative settings face selection and attrition challenges because clinical status may change rapidly. Missing follow-up data may be related directly to worsening health or death; standard assumptions of random missingness are often implausible. Trial methods must handle this transparently. Patient burden, duration, and access to support are part of the treatment evaluation.
A clinically responsible framework preserves the patient's right to choose whether to discuss difficult topics and whether to involve loved ones. Meaning-focused care cannot substitute for pain control, appropriate mental-health assessment, or decisions about medical treatment. Interdisciplinary communication becomes especially important when psychological and physical needs fluctuate rapidly.
Safety, Adverse Effects, and Suicide Risk
Psychotherapy safety involves more than the absence of a medication interaction. Possible harms include worsening distress, destabilization during exposure or memory work, inappropriate dependency, privacy breaches, missed medical deterioration, inadequate risk assessment, or treatment burden that aggravates fatigue and pain. A psychologically plausible intervention is not necessarily safe for every clinical presentation without adjustment.
The NICE depression and chronic-physical-health guideline directs clinicians to ask about suicidal ideation and intent and to respond appropriately to significant risk. Severe depression, self-neglect, psychotic symptoms, acute cognitive change, and medically unstable conditions can require coordinated or urgent specialist intervention. Standard monitoring responsibilities should be agreed among professionals rather than left implicit.
Adverse-event reporting in psychotherapy trials is frequently less systematic than symptom-outcome reporting. Researchers should distinguish treatment-related exacerbation from the natural course of disease, record deterioration with a clear definition, and report deaths and discontinuations in medical populations as relevant to trial interpretation. Absence of a recorded adverse event should not be generalized into proof of absence of harm.
The ethical basis of a treatment plan includes accessible informed consent, competence of the clinician, supervision, clear boundaries, and prompt escalation when required. This monograph presents research and clinical evidence, not an individualized diagnostic or treatment protocol.
Medication, Polypharmacy, and Coordination Limits
Many participants in psychotherapy trials for older adults or chronic illness also use prescription medications, undergo medical procedures, or receive rehabilitation. These co-interventions can affect symptoms, attendance, cognition, and outcome interpretation. Research designs should report medication changes and whether they were balanced or managed by protocol. Attributing all improvement to a psychological intervention when medications changed systematically would overstate causal specificity.
Combined-treatment studies illustrate the problem. Reynolds (1999) studied maintenance in recurrent late-life depression within pharmacological and psychotherapy conditions; Kroenke (2009) tested a package of medication optimization and pain self-management. Their findings are important for integrated care but cannot be reduced to pure psychotherapy effects.
The NICE CG91 recommendations identify medication interaction considerations when treating depression in patients with chronic physical illness. Medication selection, dosing, discontinuation, adverse reactions, and drug interaction assessment belong to licensed medical practice with current prescribing information. A psychotherapist's role includes recognizing concerns, documenting relevant changes, and coordinating with qualified prescribers.
A longitudinal psychotherapy record may include medical events that alter interpretation of mood scores. Hospitalization, surgery, new disability, and changes in symptom burden can modify both patient goals and expected treatment exposure. These events need careful clinical documentation and appropriate trial analysis.
Ageism, Ableism, and Research Representation
Health care is affected by beliefs about aging and disability that can shape referral, consent, and expectations of treatment benefit. Assuming that depression is inevitable in old age can delay assessment. Assuming that disability eliminates agency can lead professionals to address caregivers instead of the patient. Such patterns matter because an intervention cannot show effectiveness in a population that services systematically fail to enroll.
The American Psychological Association. (2024). Guidelines for psychological practice with older adults. American Psychological Association. https://www.apa.org/practice/guidelines/older-adults.aspx (2024) emphasize examination of personal assumptions about older adults and contextual understanding of functioning. Accessibility is therefore both a practical treatment condition and a determinant of the evidence base. Trials that exclude people because of unaccommodated communication barriers create selection bias under the appearance of methodological convenience.
Research participation should report relevant demographic and functional characteristics without reducing people to impairment categories. Recruitment from affluent urban specialty centers may yield an evidence base with limited transportability to rural, low-income, or linguistically diverse populations. The Choi (2020) explicitly targeted homebound, low-income adults and provides a model for studying an underserved group rather than relying solely on convenience samples.
Future trial designs can strengthen representation by budgeting for accessible consent materials, transportation, interpreters, flexible sessions, and community partnerships. Such accommodations should be described as substantive methodological features, allowing investigators to study their relation to enrollment and retention.
Clinical Service Organization and Stepped-Care Decisions
Stepped care allocates intervention intensity according to need, preference, severity, previous response, and practical resources. It requires reliable assessment and an explicit process for changing course. For older adults with medical comorbidity, under-treatment and excessive treatment burden are both possible. The correct initial step depends on the clinical condition and the person's goals rather than on age as a categorical rule.
The NICE chronic-physical-health recommendations describe low-intensity and high-intensity psychological approaches, collaboration among services, and escalation for complex or severe depression. These recommendations are jurisdiction-specific clinical guidance and should be interpreted alongside current local standards, patient preference, and available care. They provide a structured framework for decision-making, not evidence that a single sequence fits every individual.
The prevention trial by van't Veer-Tazelaar (2009) demonstrates that stepping through preventive options can be evaluated empirically in a precisely defined group. It is methodologically distinct from trials of stepped treatment for diagnosed severe depression. Prevention and treatment pathways must therefore be assessed with their own endpoints, safety procedures, and comparators.
Service integration is also a question of implementation fidelity. A program that lacks supervision, specialist consultation, follow-up, or accessible referral mechanisms may carry the name collaborative care while omitting components associated with studied interventions. Implementation research should report these details rather than treating the setting as a neutral background.
Comparative Effectiveness and Treatment Selection
The selection of psychotherapy should integrate clinical formulation, credible evidence, treatment preference, accessibility, and the likely burden of attendance. For depressive symptoms in later life, multiple treatments have supportive randomized evidence; for dementia-related anxiety or severe disability, the comparative evidence is narrower. A modality with a favorable pooled mean effect may be impractical if its delivery excludes the individual who needs care.
The Cuijpers (2026) reported broadly comparable effectiveness across several structured therapies for older-adult depression, with sensitivity analyses limiting strong rankings. The Jahoda (2017) found no demonstrated superiority between two active adapted interventions for depression in adults with intellectual disability. Taken together, these findings support treatment matching guided by patient characteristics and preference, while resisting an unsupported universal hierarchy.
Cross-study comparisons are often confounded by differences in baseline severity, setting, treatment dose, comparator intensity, and outcome instruments. Network meta-analysis adds assumptions of similarity and transitivity across trial comparisons; disagreement between direct and indirect comparisons is an important diagnostic signal. Researchers should examine those assumptions before presenting a rank order as a clinical algorithm.
Treatment choice is an ongoing decision. Monitoring should establish whether the person received adequate exposure and experienced changes that matter to them. Limited response can justify reassessment of diagnosis, therapeutic fit, accommodation, medical factors, or care coordination, depending on clinical circumstances and professional responsibility.
Methodological Limitations, Replication, and Evidence Gaps
The evidence base remains uneven. Late-life depression has a comparatively developed psychotherapy trial literature, whereas treatment trials including advanced multimorbidity, severe dementia, multiple simultaneous disabilities, and complex communication needs are less common. Studies frequently vary in the age threshold, intervention classification, outcome measures, follow-up duration, and reporting of additional services. These differences can obscure which conclusions are truly transferable.
Attrition in medically ill populations is often informative rather than random. Hospitalization, deterioration, caregiving crises, and death may interrupt participation. A complete-case analysis can overrepresent those who remain healthy enough to complete follow-up. Intention-to-treat estimation, prespecified handling of missingness, sensitivity analyses, and transparent reasons for withdrawal are important safeguards.
Replication should be differentiated from accumulation. Repeated results from overlapping samples or systematic reviews sharing trials do not constitute fully independent corroboration. For example, the pain ACT reviews by Ma (2023) and Lai (2023) involve overlapping research traditions and should be read for their distinct methods rather than added together as independent populations.
Better studies will incorporate preregistered primary outcomes, well-specified active comparators, accessibility reporting, subgroup representation, therapist training, adverse events, and functional follow-up. Trials that involve multiple care components should report their contribution and treatment fidelity as explicitly as practical. Scientific synthesis must preserve uncertainty where methods cannot isolate a proposed mechanism.
Research Agenda for Psychotherapy in Complex Health Conditions
The first research priority is to establish how adaptations influence actual treatment exposure and benefit. Trials can compare accessible delivery packages, measure comprehension and participation, and test whether format changes preserve key psychological processes. Such research could include randomized or adaptive designs when ethically and operationally feasible, complemented by qualitative accounts of what participants find useful or burdensome.
A second priority is transportability. The field needs prospective studies that include participants across different levels of functional impairment, socioeconomic conditions, and care settings. Recording reasons for nonparticipation and differential loss to follow-up would illuminate where the evidence excludes those with the greatest needs. Recruitment in home care, rehabilitation, primary care, and long-term care can increase representativeness.
A third priority is outcome alignment. Depression scores remain valuable, but participation, personal goals, treatment burden, dignity, and the quality of coordination often determine clinical relevance. Studies should evaluate whether improvements persist across health events and whether psychological benefits remain meaningful when the underlying medical condition progresses. Economic evaluations should account for the time and resources required by patients and supporters.
Finally, research should examine responsible use of digital and artificial systems for administrative support, accessible communication, monitoring, and information organization. Such systems create questions about privacy, accountability, clinical oversight, and measurement validity. Their value in psychotherapy for medically complex groups requires direct empirical evaluation; plausible technical assistance cannot be equated with proven psychotherapy efficacy.
Critical Scientific Discussion
Evidence strongly supports the proposition that psychological interventions can improve depressive symptoms in many older adults, while estimates of comparative superiority remain vulnerable to comparator selection, heterogeneity, and differences in study design. The field has moved beyond the historical assumption that advanced age necessarily precludes psychotherapeutic response. However, age alone explains little about why an individual will benefit. Functional characteristics, treatment setting, comorbidity, environmental access, clinical formulation, and intervention integrity shape observed effects.
The disability literature presents an asymmetry between feasibility and efficacy. Therapists have documented numerous promising adaptations, but reporting an accommodation is not equivalent to proving that it improved clinical outcomes. The large Poku (2026) review systematically catalogued modifications yet emphasized the need for stronger effectiveness research. The active-treatment comparison in Jahoda (2017) provides a valuable corrective: even plausible, structured adapted interventions may not outperform a simpler alternative on the primary endpoint.
Medical comorbidity presents a different challenge. Integrated interventions may improve mental and physical outcomes, but combined packages obscure which component produces each benefit. Studies such as Katon (2010) and Kroenke (2009) should be interpreted as evidence about coordinated programs, with their medical contributions intact. Separating psychotherapy effects from care management or medication is a question for further experimental designs.
The strongest general synthesis is conditional and clinically substantive: psychological treatment can be effective across several later-life and medically complex circumstances when interventions are appropriately matched, delivered, adapted, monitored, and coordinated. The corresponding scientific obligation is to specify which populations, comparators, mechanisms, and outcomes support each claim.
Conclusion
Psychotherapy in later life, disability, and medical comorbidity is a multidisciplinary clinical research field organized around the relationship between psychological treatment mechanisms and the real conditions of human functioning. Its major contributions are evidence that structured psychotherapies benefit many older adults with depression, growing empirical support for accessible and remotely delivered interventions, and randomized demonstrations that depression care can be integrated with treatment of physical illness.
The principal limitations arise at the boundaries of existing trials. Severe or overlapping disabilities, advanced multimorbidity, and cognitive decline are variably represented. Adaptations are often well described without being directly tested. Combined medical–psychological interventions establish the value of care packages while complicating attribution to individual components. Longitudinal outcomes, treatment burden, safety reporting, and patient-defined functioning deserve more consistent study.
The field's enduring scientific direction is toward treatment defined by the individual psychological problem, measurable mechanisms, accessible delivery, and coordination across health contexts. It requires evidence-sensitive clinical decisions, transparent reporting of uncertainty, and respect for each person's agency and goals. That framework supports rigorous inquiry into psychotherapy wherever later-life transitions, disability, and complex medical conditions intersect.
References
- American Psychological Association. (2024). Guidelines for psychological practice with older adults. American Psychological Association. https://www.apa.org/practice/guidelines/older-adults.aspx
- Ang, L., Lee, M. S., Song, E., Lee, H. W., Cao, L., Zhang, J., Wang, Q., Jung, J., Jang, S., Gastaldon, C., Reynolds, C. F., Cuijpers, P., Patel, V., Barbui, C., Yao, L., & Papola, D. (2024). Psychotherapeutic treatments for depression in older adults [Cochrane review protocol]. Cochrane Database of Systematic Reviews, 2024(11), CD015976. https://doi.org/10.1002/14651858.CD015976
- Areán, P. A., Raue, P., Mackin, R. S., Kanellopoulos, D., McCulloch, C., & Alexopoulos, G. S. (2010). Problem-solving therapy and supportive therapy in older adults with major depression and executive dysfunction. American Journal of Psychiatry, 167(11), 1391–1398. https://doi.org/10.1176/appi.ajp.2010.09091327
- Chochinov, H. M., Kristjanson, L. J., Breitbart, W., McClement, S., Hack, T. F., Hassard, T., & Harlos, M. (2011). Effect of dignity therapy on distress and end-of-life experience in terminally ill patients: A randomised controlled trial. The Lancet Oncology, 12(8), 753–762. https://doi.org/10.1016/S1470-2045(11)70153-X
- Choi, N. G., Marti, C. N., Wilson, N. L., Chen, G. J., Sirrianni, L., Hegel, M. T., Bruce, M. L., & Kunik, M. E. (2020). Effect of telehealth treatment by lay counselors vs by clinicians on depressive symptoms among older adults who are homebound: A randomized clinical trial. JAMA Network Open, 3(8), e2015648. https://doi.org/10.1001/jamanetworkopen.2020.15648
- Cooney, P., Jackman, C., Coyle, D., & O'Reilly, G. (2017). Computerised cognitive-behavioural therapy for adults with intellectual disability: Randomised controlled trial. British Journal of Psychiatry, 211(2), 95–102. https://doi.org/10.1192/bjp.bp.117.198630
- Cuijpers, P., Miguel, C., Karyotaki, E., & Harrer, M. (2026). Psychological treatment of depression in older adults: A network meta-analysis. International Psychogeriatrics, 38(5), 100213. https://doi.org/10.1016/j.inpsyc.2026.100213
- Egede, L. E., Acierno, R., Knapp, R. G., Lejuez, C., Hernandez-Tejada, M., Payne, E. H., & Frueh, B. C. (2015). Psychotherapy for depression in older veterans via telemedicine: A randomised, open-label, non-inferiority trial. The Lancet Psychiatry, 2(8), 693–701. https://doi.org/10.1016/S2215-0366(15)00122-4
- Jahoda, A., Hastings, R., Hatton, C., Cooper, S.-A., Dagnan, D., Zhang, R., McConnachie, A., McMeekin, N., Appleton, K., Jones, R., Scott, K., Fulton, L., Knight, R., Knowles, D., Williams, C., Briggs, A., MacMahon, K., Lynn, H., Smith, I.,. Melville, C. (2017). Comparison of behavioural activation with guided self-help for treatment of depression in adults with intellectual disabilities: A randomised controlled trial. The Lancet Psychiatry, 4(12), 909–919. https://doi.org/10.1016/S2215-0366(17)30426-1
- Katon, W. J., Lin, E. H. B., Von Korff, M., Ciechanowski, P., Ludman, E. J., Young, B., Peterson, D., Rutter, C. M., McGregor, M., & McCulloch, D. (2010). Collaborative care for patients with depression and chronic illnesses. New England Journal of Medicine, 363(27), 2611–2620. https://doi.org/10.1056/NEJMoa1003955
- Kroenke, K., Bair, M. J., Damush, T. M., Wu, J., Hoke, S., Sutherland, J., & Tu, W. (2009). Optimized antidepressant therapy and pain self-management in primary care patients with depression and musculoskeletal pain: A randomized controlled trial. JAMA, 301(20), 2099–2110. https://doi.org/10.1001/jama.2009.723
- Lai, L., Liu, Y., McCracken, L. M., Li, Y., & Ren, Z. (2023). The efficacy of acceptance and commitment therapy for chronic pain: A three-level meta-analysis and a trial sequential analysis of randomized controlled trials. Behaviour Research and Therapy, 165, 104308. https://doi.org/10.1016/j.brat.2023.104308
- Ma, T.-W., Yuen, A. S.-K., & Yang, Z. (2023). The efficacy of acceptance and commitment therapy for chronic pain: A systematic review and meta-analysis. The Clinical Journal of Pain, 39(3), 147–157. https://doi.org/10.1097/AJP.0000000000001096
- National Institute for Health and Care Excellence. (2009; reviewed 2024). Depression in adults with a chronic physical health problem: Recognition and management (CG91). https://www.nice.org.uk/guidance/cg91
- Orgeta, V., Leung, P., Del-Pino-Casado, R., Qazi, A., Orrell, M., Spector, A. E., & Methley, A. M. (2022). Psychological treatments for depression and anxiety in dementia and mild cognitive impairment. Cochrane Database of Systematic Reviews, 2022(4), CD009125. https://doi.org/10.1002/14651858.CD009125.pub3
- Poku, A. C., Gray, K. M., Hewitt, O., & Langdon, P. E. (2026). Adapting psychological therapies for individuals with intellectual disabilities: A systematic review. Clinical Psychology & Psychotherapy, 33(1), e70202. https://doi.org/10.1002/cpp.70202
- Reynolds, C. F., III, Frank, E., Perel, J. M., Imber, S. D., Cornes, C., Miller, M. D., Mazumdar, S., Houck, P. R., Dew, M. A., Stack, J. A., Pollock, B. G., & Kupfer, D. J. (1999). Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: A randomized controlled trial in patients older than 59 years. JAMA, 281(1), 39–45. https://doi.org/10.1001/jama.281.1.39
- Unützer, J., Katon, W., Callahan, C. M., Williams, J. W., Jr., Hunkeler, E., Harpole, L., Hoffing, M., Della Penna, R. D., Noël, P. H., Lin, E. H. B., Areán, P. A., Hegel, M. T., Tang, L., Belin, T. R., Oishi, S., & Langston, C. (2002). Collaborative care management of late-life depression in the primary care setting: A randomized controlled trial. JAMA, 288(22), 2836–2845. https://doi.org/10.1001/jama.288.22.2836
- van't Veer-Tazelaar, P. J., van Marwijk, H. W. J., van Oppen, P., van Hout, H. P. J., van der Horst, H. E., Cuijpers, P., Smit, F., & Beekman, A. T. F. (2009). Stepped-care prevention of anxiety and depression in late life: A randomized controlled trial. Archives of General Psychiatry, 66(3), 297–304. https://doi.org/10.1001/archgenpsychiatry.2008.555
- World Health Organization. (2023). Psychological therapies for people with dementia and comorbid depression [mhGAP evidence recommendation]. https://www.who.int/teams/mental-health-and-substance-use/treatment-care/mental-health-gap-action-programme/evidence-centre/dementia/psychological-therapies-for-people-with-dementia-who-have-associated-depression